TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
9/30/24 20:38 | 9/30/24 | TVTX | Travere Therapeutics, Inc. | CA | Health | Drug | Pharmaceutical Preparations | Meckler Jeffrey A | CA | D | M.d | 419 | 10.48 | 0 | 40 | 98 | 81 | D | |||||||||||||||
9/30/24 20:38 | 9/30/24 | TVTX | Travere Therapeutics, Inc. | CA | Health | Drug | Pharmaceutical Preparations | Meckler Jeffrey A | CA | D | S.d | -562 | 14.06 | 0 | -40 | -33 | 81 | D | |||||||||||||||
11/22/22 08:00 | 11/18/22 | INDP | Indaptus Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Meckler Jeffrey A | NY | DO | CEO,Dir | P.m | 19 | 1.89 | 0 | 10 | 15 | 75 | D | ||||||||||||||
9/12/22 09:00 | 9/8/22 | INDP | Indaptus Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Meckler Jeffrey A | NY | DO | CEO,Dir | P | 29 | 2.80 | 0 | 10 | 19 | 65 | D | ||||||||||||||
9/8/22 09:00 | 9/6/22 | INDP | Indaptus Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Meckler Jeffrey A | NY | DO | CEO,Dir | P.m | 25 | 2.56 | 0 | 10 | 21 | 55 | D | ||||||||||||||
6/7/22 08:00 | 6/6/22 | INDP | Indaptus Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Meckler Jeffrey A | NY | DO | CEO,Dir | P | 52 | 2.63 | 0 | 20 | 77 | 45 | D |
D | Derivative transaction in filing (usually option exercise) |
M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
A | Amended filing |
E | Error detected in filing |
S - Sale | Sale of securities on an exchange or to another person |
S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
P - Purchase | Purchase of securities on an exchange or from another person |